Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Answer: January Coding Challenge

Staff  |  January 1, 2013

Identifying multiple determining factors—including prescription drug management, drug therapy, and chronic illness with severe exacerbation, progression, or side effects to treatment—in determining the level of risk in the medical decision making for a patient with rheumatoid arthritis

A Spotlight on IgG4-Related Disease

Emine Atac, MD, and John H. Stone, MD, MPH  |  January 1, 2013

What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)

ACR/ARHP Annual Meeting 2012: Rheumatology Professionals Turn Out by the Thousands

Susan Bernstein  |  January 1, 2013

The American College of Rheumatology’s (ACR) once-intimate annual gathering of rheumatologists has matured into a meeting for more than 12,000 professionals in the field

ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront

Mary Beth Nierengarten  |  January 1, 2013

Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights

The ACR Helps Members Meet Insurance Challenges

Audrey B. Uknis, MD  |  January 1, 2013

The Affiliate Society Council (ASC) and Insurance Subcommittee (ISC) support rheumatologists at a local level, while serving as a national voice for members

ACR Benchmark Survey Will Support Practice Management

Staff  |  January 1, 2013

The survey will compile information on the structure of physician supply and its relationship to demand for healthcare services, and raise awareness to issues facing rheumatology practices

ACR/ARHP Annual Meeting 2012: Identify Compliance Risks to Avoid Violating Medicare Rules

Mary Beth Nierengarten  |  January 1, 2013

Rheumatologists should develop a plan to keep in step with federal regulations

ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?

Thomas R. Collins  |  January 1, 2013

Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit

ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis

Thomas R. Collins  |  January 1, 2013

Rheumatology experts urge caution in using bisphosphonates to prevent bone loss

Was Gout Rampant Among the Romans?

Simon M. Helfgott, MD  |  January 1, 2013

Lead in wine consumed by Romans may have contributed to a high incidence of gout among aristocrats of the Roman Empire

  • « Previous Page
  • 1
  • …
  • 667
  • 668
  • 669
  • 670
  • 671
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences